(Q36905848)

English

The direct thrombin inhibitor ximelagatran/melagatran: a systematic review on clinical applications and an evidence based assessment of risk benefit profile.

scientific article published on July 2007

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17688383%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

1 reference

Europe PubMed Central

The direct thrombin inhibitor ximelagatran/melagatran: a systematic review on clinical applications and an evidence based assessment of risk benefit profile (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17688383%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

systematic review

1 reference

based on heuristic

inferred from title

Pierfrancesco Agostoni

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17688383%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

author name string

Luca Testa

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17688383%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

Ravinai Bhindi

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17688383%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

Antonio Abbate

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17688383%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

Guiseppe Gl Biondi Zoccai

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17688383%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

William J van Gaal

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17688383%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

language of work or name

0 references

publication date

1 July 2007

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17688383%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

Expert Opinion on Drug Safety

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17688383%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17688383%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17688383%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

397-406

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17688383%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

New anticoagulants: anti IIa vs anti Xa--is one better?

1 reference

https://api.crossref.org/works/10.1517%2F14740338.6.4.397

21 January 2018

Direct thrombin inhibitors

1 reference

https://api.crossref.org/works/10.1517%2F14740338.6.4.397

21 January 2018

A review of the clinical uses of ximelagatran in thrombosis syndromes

1 reference

https://api.crossref.org/works/10.1517%2F14740338.6.4.397

21 January 2018

A simple hint to improve Robinson and Dickersin's highly sensitive PubMed search strategy for controlled clinical trials.

1 reference

https://api.crossref.org/works/10.1517%2F14740338.6.4.397

21 January 2018

Comparison of the oral direct thrombin inhibitor ximelagatran with enoxaparin as prophylaxis against venous thromboembolism after total knee replacement: a phase 2 dose-finding study

1 reference

https://api.crossref.org/works/10.1517%2F14740338.6.4.397

21 January 2018

Ximelagatran and melagatran compared with dalteparin for prevention of venous thromboembolism after total hip or knee replacement: the METHRO II randomised trial

1 reference

https://api.crossref.org/works/10.1517%2F14740338.6.4.397

21 January 2018

Ximelagatran versus warfarin for the prevention of venous thromboembolism after total knee arthroplasty. A randomized, double-blind trial

1 reference

https://api.crossref.org/works/10.1517%2F14740338.6.4.397

21 January 2018

Comparison of ximelagatran, an oral direct thrombin inhibitor, with enoxaparin for the prevention of venous thromboembolism following total hip replacement. A randomized, double-blind study.

1 reference

https://api.crossref.org/works/10.1517%2F14740338.6.4.397

21 January 2018

The direct thrombin inhibitor melagatran followed by oral ximelagatran compared with enoxaparin for the prevention of venous thromboembolism after total hip or knee replacement: the EXPRESS study

1 reference

https://api.crossref.org/works/10.1517%2F14740338.6.4.397

21 January 2018

Comparison of ximelagatran with warfarin for the prevention of venous thromboembolism after total knee replacement.

1 reference

https://api.crossref.org/works/10.1517%2F14740338.6.4.397

21 January 2018

A randomized, controlled, dose-guiding study of the oral direct thrombin inhibitor ximelagatran compared with standard therapy for the treatment of acute deep vein thrombosis: THRIVE I.

1 reference

https://api.crossref.org/works/10.1517%2F14740338.6.4.397

21 January 2018

Ximelagatran vs low-molecular-weight heparin and warfarin for the treatment of deep vein thrombosis: a randomized trial.

1 reference

https://api.crossref.org/works/10.1517%2F14740338.6.4.397

21 January 2018

Ximelagatran versus warfarin for stroke prevention in patients with nonvalvular atrial fibrillation. SPORTIF II: a dose-guiding, tolerability, and safety study

1 reference

https://api.crossref.org/works/10.1517%2F14740338.6.4.397

21 January 2018

Ximelagatran vs warfarin for stroke prevention in patients with nonvalvular atrial fibrillation: a randomized trial

1 reference

https://api.crossref.org/works/10.1517%2F14740338.6.4.397

21 January 2018

Oral ximelagatran for secondary prophylaxis after myocardial infarction: the ESTEEM randomised controlled trial

1 reference

https://api.crossref.org/works/10.1517%2F14740338.6.4.397

21 January 2018

Secondary Prevention of Venous Thromboembolism with the Oral Direct Thrombin Inhibitor Ximelagatran

1 reference

https://api.crossref.org/works/10.1517%2F14740338.6.4.397

21 January 2018

American Heart Association/American College of Cardiology Foundation Guide to Warfarin Therapy

1 reference

https://api.crossref.org/works/10.1517%2F14740338.6.4.397

21 January 2018

Identifiers

10.1517/14740338.6.4.397

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17688383%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17688383%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36905848&oldid=2088508032"